Literature DB >> 9466751

Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients.

T Na'was1, A Hawwari, E Hendrix, J Hebden, R Edelman, M Martin, W Campbell, R Naso, R Schwalbe, A I Fattom.   

Abstract

Staphylococcus aureus is a major cause of nosocomial infections. During the period from March 1992 to March 1994, the patients admitted to the intensive care unit of the University of Maryland Shock Trauma Center were monitored for the development of S. aureus infections. Among the 776 patients eligible for the study, 60 (7.7%) patients developed 65 incidents of nosocomial S. aureus infections. Of the clinical isolates, 43.1% possessed a polysaccharide type 5 capsule, 44.6% possessed a type 8 capsule, and the remaining 12.3% had capsules that were not typed by the type 5 or type 8 antibodies. Six antibiogram types were noted among the infection-related isolates, with the majority of the types being resistant only to penicillin and ampicillin. It was noted that the majority of cases of pneumonia were caused by relatively susceptible strains, while resistant strains were isolated from patients with bacteremia and other infections. Only 16 (6.3%) of the isolates were found to be methicillin-resistant S. aureus (MRSA). DNA fingerprinting by pulsed-field gel electrophoresis showed 36 different patterns, with characteristic patterns being found for MRSA strains and the strains with different capsular types. Clonal relationships were established, and the origins of the infection-related isolates in each patient were determined. We conclude that (i) nosocomial infection-related isolates from the shock trauma patients did not belong to a single clone, although the predominance of a methicillin-resistant genotype was noted, (ii) most infection-related S. aureus isolates were relatively susceptible to antibiotics, but a MRSA strain was endemic, and (iii) for practical purposes, the combination of the results of capsular and antibiogram typing can be used as a useful epidemiological marker.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466751      PMCID: PMC104552     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  38 in total

1.  DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates.

Authors:  G Prevost; B Jaulhac; Y Piemont
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia.

Authors:  O Jessen; K Rosendal; P Bülow; V Faber; K R Eriksen
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

3.  Comparison of phage typing, plasmid mapping, and antibiotic resistance patterns as epidemiologic markers in a nosocomial outbreak of methicillin-resistant Staphylococcus aureus infections.

Authors:  J K Collins; J S Smith; M T Kelly
Journal:  Diagn Microbiol Infect Dis       Date:  1984-06       Impact factor: 2.803

4.  New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

5.  Numerical analysis of electrophoretic protein patterns of methicillin-resistant strains of Staphylococcus aureus.

Authors:  M Costas; B D Cookson; H G Talsania; R J Owen
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

6.  Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.

Authors:  V L Yu; A Goetz; M Wagener; P B Smith; J D Rihs; J Hanchett; J J Zuravleff
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

7.  Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships.

Authors:  C Schlichting; C Branger; J M Fournier; W Witte; A Boutonnier; C Wolz; P Goullet; G Döring
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Restriction enzyme analysis of plasmid DNA and bacteriophage typing of paired Staphylococcus aureus blood culture isolates.

Authors:  A I Hartstein; V H Morthland; S Eng; G L Archer; F D Schoenknecht; A L Rashad
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

9.  Characterization of Staphylococcus species by ribosomal RNA gene restriction patterns.

Authors:  M L De Buyser; A Morvan; F Grimont; N el Solh
Journal:  J Gen Microbiol       Date:  1989-04

10.  Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.

Authors:  A Fattom; R Schneerson; D C Watson; W W Karakawa; D Fitzgerald; I Pastan; X Li; J Shiloach; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.609

View more
  21 in total

1.  Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis?

Authors:  A Strandén; R Frei; A F Widmer
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.

Authors:  Isabelle Verdier; Geraldine Durand; Michele Bes; Kimberly L Taylor; Gerard Lina; François Vandenesch; Ali I Fattom; Jerome Etienne
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

3.  Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy.

Authors:  Tom Grunert; Mareike Wenning; María Sol Barbagelata; Martina Fricker; Daniel O Sordelli; Fernanda R Buzzola; Monika Ehling-Schulz
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

4.  Molecular analysis of Staphylococcus aureus blood isolates shows lack of polyclonal bacteremia.

Authors:  Riad Khatib; Mamta Sharma; S Anwar H Naqvi; Kathleen Riederer; Mohammed O Almoujahed; Mohamad G Fakih
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Epidemiologic genotyping of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis at a university hospital and comparison with antibiotyping and protein A and coagulase gene polymorphisms.

Authors:  I Montesinos; E Salido; T Delgado; M Cuervo; A Sierra
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Genetic background and antibiotic resistance of Staphylococcus aureus strains isolated in the Republic of Georgia.

Authors:  Tamara Revazishvili; Lela Bakanidze; Tsaro Gomelauri; Ekaterine Zhgenti; Gvantsa Chanturia; Merab Kekelidze; Chythanya Rajanna; Arnold Kreger; Alexander Sulakvelidze
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Capsule production and growth phase influence binding of complement to Staphylococcus aureus.

Authors:  K M Cunnion; J C Lee; M M Frank
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Rapid identification and typing of Staphylococcus aureus by PCR-restriction fragment length polymorphism analysis of the aroA gene.

Authors:  J Y Marcos; A C Soriano; M S Salazar; C H Moral; S S Ramos; M S Smeltzer; G N Carrasco
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.

Authors:  K M Cunnion; P S Hair; E S Buescher
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.

Authors:  K M Cunnion; H-M Zhang; M M Frank
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.